Multimodal imaging diagnosis and analysis of prognostic factors in patients with adult-onset Coats disease.

Autor:	Zhou W; Department of Ophthalmology, Tianjin Medical University General Hospital, Tianjin 300052, China., Zhou H; Department of Ophthalmology, Tianjin Medical University General Hospital, Tianjin 300052, China., Liu YY; Department of Ophthalmology, Tianjin Medical University General Hospital, Tianjin 300052, China., Li MX; Department of Ophthalmology, Tianjin Medical University General Hospital, Tianjin 300052, China., Wu XH; Department of Ophthalmology, Tianjin Medical University General Hospital, Tianjin 300052, China., Liang J; Department of Ophthalmology, Shanxi Yuncheng Tongde Hospital, Yuncheng 044000, Shanxi Province, China., Hao J; Department of Ophthalmology, Tianjin Medical University General Hospital, Tianjin 300052, China., Liu SN; Department of Ophthalmology, Tianjin Medical University General Hospital, Tianjin 300052, China., Jin CJ; Department of Information, Tianjin Medical University General Hospital, Tianjin 300052, China.
Jazyk:	angličtina
Zdroj:	International journal of ophthalmology [Int J Ophthalmol] 2024 Aug 18; Vol. 17 (8), pp. 1469-1476. Date of Electronic Publication: 2024 Aug 18 (Print Publication: 2024).
DOI:	10.18240/ijo.2024.08.12
Abstrakt:	Aim: To describe the multimodal imaging features, treatment, and outcomes of patients diagnosed with adult-onset Coats disease. Methods: This retrospective study included patients first diagnosed with Coats disease at ≥18 years of age between September 2017 and September 2021. Some patients received anti-vascular endothelial growth factor (VEGF) therapy (conbercept, 0.5 mg) as the initial treatment, which was combined with laser photocoagulation as needed. All the patients underwent best corrected visual acuity (BCVA) and intraocular pressure examinations, fundus color photography, spontaneous fluorescence tests, fundus fluorescein angiography, optical coherence tomography (OCT), OCT angiography, and other examinations. BCVA alterations and multimodal image findings in the affected eyes following treatment were compared and the prognostic factors were analyzed. Results: The study included 15 patients who were aged 24-72 (57.33±12.61)y at presentation. Systemic hypertension was the most common associated systemic condition, occurring in 13 (86.7%) patients. Baseline BCVA ranged from 2.0 to 5.0 (4.0±1.1), which showed improvement following treatment (4.2±1.0). Multimodal imaging revealed retinal telangiectasis in 13 patients (86.7%), patchy hemorrhage in 5 patients (33.3%), and stage 2B disease (Shield's staging criteria) in 11 patients (73.3%). OCT revealed that the baseline central macular thickness (CMT) ranged from 129 to 964 µm (473.0±230.1 µm), with 13 patients (86.7%) exhibiting a baseline CMT exceeding 250 µm. Furthermore, 8 patients (53.3%) presented with an epiretinal membrane at baseline or during follow-up. Hyper-reflective scars were observed on OCT in five patients (33.3%) with poor visual prognosis. Vision deteriorated in one patient who did not receive treatment. Final vision was stable in three patients who received laser treatment, whereas improvement was observed in one of two patients who received anti-VEGF therapy alone. In addition, 8 of 9 patients (88.9%) who received laser treatment and conbercept exhibited stable or improved BCVA. Conclusion: Multimodal imaging can help diagnose adult-onset Coats disease. Anti-VEGF treatment combined with laser therapy can be an option for improving or maintaining BCVA and resolving macular edema. The final visual outcome depends on macular involvement and the disease stage. Competing Interests: Conflicts of Interest: Zhou W, None; Zhou H, None; Liu YY, None; Li MX, None; Wu XH, None; Liang J, None; Hao J, None; Liu SN, None; Jin CJ, None. (International Journal of Ophthalmology Press.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu